| |
| |
|
| Insider
Information: |
Leamon Christopher P |
| Relationship: |
|
| City: |
West Lafayette |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
11,957 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$254,086 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
11,957 |
|
|
| Total
Value |
$254,086 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Endocyte Inc |
ECYT |
Vice President of Rese... |
2018-12-21 |
0 |
2011-03-24 |
0 |
Premium* |
|
|
Fusion Pharmaceuticals Inc. |
FUSN |
|
2023-08-31 |
11,957 |
2023-08-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FUSN |
Fusion Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2023-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
11,957 |
11,957 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2018-12-21 |
4 |
D |
$24.00 |
$5,382,144 |
D/D |
(224,256) |
0 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2018-12-17 |
4 |
OE |
$2.54 |
$523,489 |
D/D |
101,774 |
224,256 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2018-10-05 |
4/A |
AS |
$15.56 |
$140,437 |
D/D |
(9,028) |
122,219 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2018-10-05 |
4 |
AS |
$15.56 |
$140,437 |
D/D |
(9,028) |
121,353 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2018-08-29 |
4 |
AS |
$20.00 |
$93,920 |
D/D |
(4,696) |
130,381 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2018-08-29 |
4 |
OE |
$2.54 |
$11,928 |
D/D |
4,696 |
135,077 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2018-08-28 |
4 |
OE |
$2.54 |
$32,182 |
D/D |
12,670 |
143,051 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2018-08-28 |
4 |
AS |
$20.00 |
$253,403 |
D/D |
(12,670) |
130,381 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2018-06-12 |
4 |
AS |
$15.06 |
$197,058 |
D/D |
(13,089) |
130,381 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2018-03-09 |
4 |
AS |
$9.07 |
$45,677 |
D/D |
(5,036) |
143,470 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
148,506 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2018-02-06 |
4 |
D |
$3.00 |
$1,914 |
D/D |
(638) |
126,006 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2018-02-04 |
4 |
D |
$3.12 |
$5,416 |
D/D |
(1,736) |
126,644 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2018-02-02 |
4 |
D |
$3.12 |
$4,639 |
D/D |
(1,487) |
128,380 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2017-12-01 |
4 |
S |
$5.03 |
$116,983 |
D/D |
(23,231) |
127,348 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2017-12-01 |
4 |
OE |
$3.06 |
$80,105 |
D/D |
26,178 |
150,579 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2017-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
124,401 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2017-02-06 |
4 |
D |
$2.18 |
$1,513 |
D/D |
(694) |
81,901 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2017-02-04 |
4 |
D |
$2.18 |
$4,116 |
D/D |
(1,888) |
82,595 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2017-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
84,483 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2016-12-30 |
4 |
S |
$2.55 |
$59,272 |
D/D |
(23,244) |
66,983 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2016-12-30 |
4 |
OE |
$2.10 |
$54,974 |
D/D |
26,178 |
90,227 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2016-02-17 |
4 |
OE |
$1.91 |
$25,000 |
D/D |
13,089 |
61,548 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Vice President of Research |
• – – |
2016-02-06 |
4 |
D |
$3.02 |
$2,099 |
D/D |
(695) |
48,459 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
